FDA approves the new Alzheimer’s drug, lecanemab. Therapy should be available in US the week of Jan. 23 or before. Image Credit: seasons.com On Friday, the Food and Drug Administration (FDA) approved the Eisai and Biogen’s amyloid-targeted […] truthisacommodity 3 weeks ago Leave a Comment